title: Premature rupture of the membranes: management controversies.
abstract: Preterm premature rupture of the membranes continues to be a leading cause of perinatal morbidity and mortality in the United States. In the absence of amnionitis or fetal compromise, expectant management is a reasonable alternative to permit fetal weight gain and to allow for fetal lung maturation. When embarking on an expectant management course, a variety of clinical approaches are available to the practicing clinician.
authors.affiliation: Department of Obstetrics and Gynecology, University of Utah, Salt Lake City.
authors.forename: K A
authors.initials: KA
authors.lastname: Kennedy
authors.forename: S L
authors.initials: SL
authors.lastname: Clark
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000553:Ambulatory Care / Q000592:standards; D000649:Amniocentesis / Q000379:methods / Q000592:standards; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002985:Clinical Protocols / Q000592:standards*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D005323:Fetal Monitoring / Q000592:standards; D006760:Hospitalization; D006801:Humans; D007958:Leukocyte Count; D009774:Obstetrics / Q000379:methods / Q000592:standards*; D011237:Predictive Value of Tests; D011247:Pregnancy; D011295:Prenatal Care / Q000379:methods / Q000592:standards; D015145:Tocolysis / Q000379:methods / Q000592:standards
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents